U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198751198751Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)CompletedNo Results AvailableHIV Infections|Pregnancy|HIV SeronegativityBiological: gp160 Vaccine (MicroGeneSys)https://ClinicalTrials.gov/show/NCT00000777
198752198752Dexamethasone in Cryptococcal MeningitisCompletedNo Results AvailableMeningitis, Cryptococcal|HIV InfectionsDrug: Flucytosine|Drug: Fluconazole|Drug: Amphotericin B|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00000776
198753198753A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)CompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccinehttps://ClinicalTrials.gov/show/NCT00000775
198754198754A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected MothersCompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: rgp120/HIV-1MN|Biological: rgp120/HIV-1 SF-2|Biological: Placebo version of rgp120/HIV-1MN|Biological: Placebo version of rgp120/HIV-1SF2https://ClinicalTrials.gov/show/NCT00000774
198755198755Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and ChildrenCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Atovaquonehttps://ClinicalTrials.gov/show/NCT00000773
198756198756A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsCompletedNo Results AvailableHIV InfectionsDrug: Ribavirin|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000772
198757198757A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3CompletedNo Results AvailableCryptosporidiosis|HIV InfectionsDrug: Paromomycin sulfatehttps://ClinicalTrials.gov/show/NCT00000771
198758198758A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and DidanosineCompletedNo Results AvailableHIV InfectionsDrug: Nevirapine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000770
198759198759A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's SarcomaCompletedNo Results AvailableSarcoma, Kaposi|HIV InfectionsDrug: Interleukin-4https://ClinicalTrials.gov/show/NCT00000769
198760198760A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedNo Results AvailableColitis|HIV InfectionsDrug: Glutamic acid hydrochloride|Drug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00000768
198761198761A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)CompletedNo Results AvailableHIV InfectionsBiological: TBC-3B Vaccine|Biological: Smallpox Vaccinehttps://ClinicalTrials.gov/show/NCT00000767
198762198762CMV Retinitis Retreatment TrialCompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Foscarnet sodium|Drug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00000766
198763198763Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)CompletedNo Results AvailableHIV InfectionsDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000765
198764198764Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.CompletedNo Results AvailableHIV Infections|Anus NeoplasmsDrug: Isotretinoin|Drug: Interferon alfa-2ahttps://ClinicalTrials.gov/show/NCT00000764
198765198765A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNo Results AvailableSarcoma, Kaposi|HIV InfectionsDrug: TNP-470https://ClinicalTrials.gov/show/NCT00000763
198766198766A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV InfectionCompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1MN|Biological: rgp120/HIV-1 SF-2|Biological: gp160 Vaccine (MicroGeneSys)https://ClinicalTrials.gov/show/NCT00000762
198767198767Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Interferon gamma-1bhttps://ClinicalTrials.gov/show/NCT00000761
198768198768A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Ro 24-7429|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000760
198769198769Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical TrialsCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00000759
198770198770A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected WomenCompletedNo Results AvailableHIV Infections|Cervix, DysplasiaDrug: Fluorouracilhttps://ClinicalTrials.gov/show/NCT00000758
198771198771A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNo Results AvailableHIV InfectionsBiological: gp160 Vaccine (MicroGeneSys)https://ClinicalTrials.gov/show/NCT00000757
198772198772Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3CompletedNo Results AvailableHIV InfectionsDrug: Lymphocytes, Activatedhttps://ClinicalTrials.gov/show/NCT00000756
198773198773A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3CompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1MN|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000755
198774198774A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3CompletedNo Results AvailableHIV InfectionsDrug: Interferon alfa-2a|Drug: Zidovudine|Drug: Zalcitabinehttps://ClinicalTrials.gov/show/NCT00000754
198775198775A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddCCompletedNo Results AvailableHIV InfectionsDrug: Atevirdine mesylate|Drug: Zidovudine|Drug: Zalcitabine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000753
198776198776Preventing Frequent Sinus Infections in HIV-Infected PatientsWithdrawnNo Results AvailableHIV Infections|SinusitisDrug: Pseudoephedrine hydrochloride|Drug: Guaifenesin|Drug: Cefuroxime axetil|Drug: Beclomethasone dipropionatehttps://ClinicalTrials.gov/show/NCT00000752
198777198777A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)CompletedNo Results AvailableHIV Infections|PregnancyDrug: Anti-HIV Immune Serum Globulin (Human)|Drug: Globulin, Immune|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000751
198778198778A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000750
198779198779A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 MonthsCompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00000749
198780198780A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected PatientsCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Sulfamethoxazole-Trimethoprimhttps://ClinicalTrials.gov/show/NCT00000748

* Görseller ve İçerik tekif hakkına sahip olabilir